• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

US Breast Cancer Cases Could Increase 50% by 2030

Article

The total number of breast cancer cases in the United States is forecast to be 50% greater in 2030 than it was in 2011 driven mostly by a marked increase in cases of estrogen receptor-positive tumors.

The total number of breast cancer cases in the United States is forecast to be 50% greater in 2030 than it was in 2011, when invasive and in-situ or screening-detected cancers are counted together, and this increase is driven mostly by a marked increase in cases of estrogen receptor (ER)—positive tumors and in women older than 70 years, according to research presented at the American Association for Cancer Research Annual Meeting 2015, April 18-22.

“Managing this clinical burden will present a huge challenge,” said Philip S. Rosenberg, PhD, a senior investigator in the division of cancer epidemiology and genetics at the National Cancer Institute. “The one silver lining is that we expect fewer ER—negative tumors, which include the most difficult-to-treat HER2-positive and triple-negative subtypes.”

Read the press release: http://bit.ly/1DJKoEu

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.